Read the full stored bill text
Session of 2026
HOUSE BILL No. 2765
By Committee on Health and Human Services
Requested by W. Carpenter
2-6
AN ACT concerning controlled substances; adding and removing certain
substances in schedule I, III and IV of the uniform controlled
substances act; making conforming changes to the criminal code
definition of fentanyl-related controlled substances; amending K.S.A.
65-4109 and K.S.A. 2025 Supp. 21-5701, 65-4105 and 65-4111 and
repealing the existing sections.
Be it enacted by the Legislature of the State of Kansas:
Section 1. K.S.A. 2025 Supp. 21-5701 is hereby amended to read as
follows: 21-5701. As used in K.S.A. 21-5701 through 21-5717, and
amendments thereto:
(a) "Controlled substance" means any drug, substance or immediate
precursor included in any of the schedules designated in K.S.A. 65-4105,
65-4107, 65-4109, 65-4111 and 65-4113, and amendments thereto.
(b) (1) "Controlled substance analog" means a substance that is
intended for human consumption, and at least one of the following:
(A) The chemical structure of the substance is substantially similar to
the chemical structure of a controlled substance listed in or added to the
schedules designated in K.S.A. 65-4105 or 65-4107, and amendments
thereto;
(B) the substance has a stimulant, depressant or hallucinogenic effect
on the central nervous system substantially similar to the stimulant,
depressant or hallucinogenic effect on the central nervous system of a
controlled substance included in the schedules designated in K.S.A. 65-
4105 or 65-4107, and amendments thereto; or
(C) with respect to a particular individual, such individual represents
or intends the substance to have a stimulant, depressant or hallucinogenic
effect on the central nervous system substantially similar to the stimulant,
depressant or hallucinogenic effect on the central nervous system of a
controlled substance included in the schedules designated in K.S.A. 65-
4105 or 65-4107, and amendments thereto.
(2) "Controlled substance analog" does not include:
(A) A controlled substance;
(B) a substance for which there is an approved new drug application;
or
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
HB 2765 2
(C) a substance with respect to which an exemption is in effect for
investigational use by a particular person under section 505 of the federal
food, drug, and cosmetic act, 21 U.S.C. § 355, to the extent conduct with
respect to the substance is permitted by the exemption.
(c) "Cultivate" means the planting or promotion of growth of five or
more plants that contain or can produce controlled substances.
(d) "Distribute" means the actual, constructive or attempted transfer
from one person to another of some item whether or not there is an agency
relationship. "Distribute" includes, but is not limited to, sale, offer for sale
or any act that causes some item to be transferred from one person to
another. "Distribute" does not include acts of administering, dispensing or
prescribing a controlled substance as authorized by the pharmacy act of the
state of Kansas, the uniform controlled substances act or otherwise
authorized by law.
(e) (1) "Drug" means:
(A) Substances recognized as drugs in the official United States
pharmacopeia, official homeopathic pharmacopoeia of the United States or
official national formulary or any supplement to any of them;
(B) substances intended for use in the diagnosis, cure, mitigation,
treatment or prevention of disease in humans or animals;
(C) substances, other than food, intended to affect the structure or any
function of the body of humans or animals; and
(D) substances intended for use as a component of any article
specified in subparagraph (A), (B) or (C).
(2) "Drug" does not include devices or their components, parts or
accessories.
(f) (1) "Drug paraphernalia" means all equipment and materials of
any kind that are used, or primarily intended or designed for use in
planting, propagating, cultivating, growing, harvesting, manufacturing,
compounding, converting, producing, processing, preparing, testing,
analyzing, packaging, repackaging, storing, containing, concealing,
injecting, ingesting, inhaling or otherwise introducing into the human body
a controlled substance and in violation of this act.
(2) "Drug paraphernalia" includes, but is not limited to:
(A) Kits used or intended for use in planting, propagating, cultivating,
growing or harvesting any species of plant that is a controlled substance or
from which a controlled substance can be derived;
(B) kits used or intended for use in manufacturing, compounding,
converting, producing, processing or preparing controlled substances;
(C) isomerization devices used or intended for use in increasing the
potency of any species of plant that is a controlled substance;
(D) testing equipment used or intended for use in identifying or in
analyzing the strength, effectiveness or purity of controlled substances;
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
HB 2765 3
(E) scales and balances used or intended for use in weighing or
measuring controlled substances;
(F) diluents and adulterants, including, but not limited to, quinine
hydrochloride, mannitol, mannite, dextrose and lactose that are used or
intended for use in cutting controlled substances;
(G) separation gins and sifters used or intended for use in removing
twigs and seeds from or otherwise cleaning or refining marijuana;
(H) blenders, bowls, containers, spoons and mixing devices used or
intended for use in compounding controlled substances;
(I) capsules, balloons, envelopes, bags and other containers used or
intended for use in packaging small quantities of controlled substances;
(J) containers and other objects used or intended for use in storing or
concealing controlled substances;
(K) hypodermic syringes, needles and other objects used or intended
for use in parenterally injecting controlled substances into the human
body;
(L) objects used or primarily intended or designed for use in
ingesting, inhaling or otherwise introducing marijuana, cocaine, hashish,
hashish oil, phencyclidine (PCP), methamphetamine or amphetamine into
the human body, such as:
(i) Metal, wooden, acrylic, glass, stone, plastic or ceramic pipes with
or without screens, permanent screens, hashish heads or punctured metal
bowls;
(ii) water pipes, bongs or smoking pipes designed to draw smoke
through water or another cooling device;
(iii) carburetion pipes, glass or other heat-resistant tubes or any other
device used, intended to be used or designed to be used to cause
vaporization of a controlled substance for inhalation;
(iv) smoking and carburetion masks;
(v) roach clips, objects used to hold burning material, such as a
marijuana cigarette, that has become too small or too short to be held in
the hand;
(vi) miniature cocaine spoons and cocaine vials;
(vii) chamber smoking pipes;
(viii) carburetor smoking pipes;
(ix) electric smoking pipes;
(x) air-driven smoking pipes;
(xi) chillums;
(xii) bongs;
(xiii) ice pipes or chillers;
(xiv) any smoking pipe manufactured to disguise its intended
purpose;
(xv) wired cigarette papers; or
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
HB 2765 4
(xvi) cocaine freebase kits.
(3) "Drug paraphernalia" does not include:
(A) Any products, chemicals or materials described in K.S.A. 21-
5709(a), and amendments thereto; or
(B) any materials used or intended for use to test a substance for the
presence of fentanyl, a fentanyl analog, ketamine or gamma
hydroxybutyric acid.
(g) "Fentanyl-related controlled substance" means any substance
designated in K.S.A. 65-4105(b)(1), (b)(2), (b)(4), (b)(10), (b)(11), (b)
(12), (b)(15), (b)(16), (b)(17), (b)(20), (b)(21), (b)(24), (b)(26), (b)(27), (b)
(28), (b)(35), (b)(42), (b)(43), (b)(44), (b)(45), (b)(48), (b)(50), (b)(54), (b)
(55), (b)(56), (b)(57), (b)(58), (b)(59), (b)(68), (b)(70), (b)(71), (b)(72), (b)
(73), (b)(74), (b)(75), (b)(76), (b)(77), (b)(78), (b)(79), (b)(80), (b)(81), (b)
(82), (b)(83), (b)(84), (b)(85), (b)(91), (b)(97), (b)(98), (b)(99), (b)(103),
(b)(104) (b)(66) , (g)(1) or, (g)(2) , (i) or 65-4107(c)(1), (c)(6), (c)(9), (c)
(26), (c)(28), (c)(30), (f)(3)(A) or (f)(3)(B), and amendments thereto, or
any analog thereof.
(h) "Immediate precursor" means a substance that the state board of
pharmacy has found to be and by rules and regulations designates as being
the principal compound commonly used or produced primarily for use and
that is an immediate chemical intermediary used or likely to be used in the
manufacture of a controlled substance, the control of which is necessary to
prevent, curtail or limit manufacture.
(i) "Isomer" means all enantiomers and diastereomers.
(j) "Manufacture" means the production, preparation, propagation,
compounding, conversion or processing of or placing into pill or capsule
form a controlled substance either directly or indirectly or by extraction
from substances of natural origin or independently by means of chemical
synthesis or by a combination of extraction and chemical synthesis.
"Manufacture" does not include:
(1) The preparation or compounding of a controlled substance by an
individual for the individual's own lawful use or the preparation,
compounding, packaging or labeling of a controlled substance:
(A) By a practitioner or the practitioner's agent pursuant to a lawful
order of a practitioner as an incident to the practitioner's administering or
dispensing of a controlled substance in the course of the practitioner's
professional practice; or
(B) by a practitioner or by the practitioner's authorized agent under
such practitioner's supervision for the purpose of or as an incident to
research, teaching or chemical analysis or by a pharmacist or medical care
facility as an incident to dispensing of a controlled substance; or
(2) the addition of diluents or adulterants, including, but not limited
to, quinine hydrochloride, mannitol, mannite, dextrose or lactose that are
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
HB 2765 5
intended for use in cutting a controlled substance.
(k) "Marijuana" means all parts of all varieties of the plant Cannabis
whether growing or not, the seeds thereof, the resin extracted from any
part of the plant and every compound, manufacture, salt, derivative,
mixture or preparation of the plant, its seeds or resin. "Marijuana" does not
include:
(1) The mature stalks of the plant, fiber produced from the stalks, oil
or cake made from the seeds of the plant, any other compound,
manufacture, salt, derivative, mixture or preparation of the mature stalks,
except the resin extracted therefrom, fiber, oil or cake or the sterilized seed
of the plant that is incapable of germination;
(2) any substance listed in schedules II through V of the uniform
controlled substances act;
(3) drug products approved by the United States food and drug
administration as of the effective date of this act;
(4) cannabidiol (other trade name: 2-[(3-methyl-6-(1-methylethenyl)-
2-cyclohexen-1-yl]-5-pentyl-1,3-benzenediol); or
(5) industrial hemp as defined in K.S.A. 2-3901, and amendments
thereto, when cultivated, produced, possessed or used for activities
authorized by the commercial industrial hemp act.
(l) "Minor" means a person under 18 years of age.
(m) "Narcotic drug" means any of the following whether produced
directly or indirectly by extraction from substances of vegetable origin or
independently by means of chemical synthesis or by a combination of
extraction and chemical synthesis:
(1) Opium and opiate and any salt, compound, derivative or
preparation of opium or opiate;
(2) any salt, compound, isomer, derivative or preparation thereof that
is chemically equivalent or identical with any of the substances referred to
in paragraph (1) but not including the isoquinoline alkaloids of opium;
(3) opium poppy and poppy straw;
(4) coca leaves and any salt, compound, derivative or preparation of
coca leaves and any salt, compound, isomer, derivative or preparation
thereof that is chemically equivalent or identical with any of these
substances, but not including decocainized coca leaves or extractions of
coca leaves that do not contain cocaine or ecgonine.
(n) "Opiate" means any substance having an addiction-forming or
addiction-sustaining liability similar to morphine or being capable of
conversion into a drug having addiction-forming or addiction-sustaining
liability. "Opiate" does not include, unless specifically designated as
controlled under K.S.A. 65-4102, and amendments thereto, the
dextrorotatory isomer of 3-methoxy-n-methylmorphinan and its salts
(dextromethorphan). "Opiate" does include its racemic and levorotatory
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
HB 2765 6
forms.
(o) "Opium poppy" means the plant of the species Papaver
somniferum l. except its seeds.
(p) "Person" means an individual, corporation, government or
governmental subdivision or agency, business trust, estate, trust,
partnership, association or any other legal entity.
(q) "Poppy straw" means all parts, except the seeds, of the opium
poppy, after mowing.
(r) "School property" means property upon which is located a
structure used by a unified school district or an accredited nonpublic
school for student instruction or attendance or extracurricular activities of
pupils enrolled in kindergarten or any of the grades one through 12. This
definition shall not be construed as requiring that school be in session or
that classes are actually being held at the time of the offense or that
children must be present within the structure or on the property during the
time of any alleged criminal act. If the structure or property meets the
above definition, the actual use of that structure or property at the time
alleged shall not be a defense to the crime charged or the sentence
imposed.
(s) "Simulated controlled substance" means any product that
identifies itself by a common name or slang term associated with a
controlled substance and that indicates on its label or accompanying
promotional material that the product simulates the effect of a controlled
substance.
Sec. 2. K.S.A. 2025 Supp. 65-4105 is hereby amended to read as
follows: 65-4105. (a) The controlled substances listed in this section are
included in schedule I and the number set forth opposite each drug or
substance is the DEA controlled substances code that has been assigned to
it.
(b) Any of the following opiates, including their isomers, esters,
ethers, salts, and salts of isomers, esters and ethers, unless specifically
excepted, whenever the existence of these isomers, esters, ethers and salts
is possible within the specific chemical designation:
(1) Acetyl fentanyl
(N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide) 9821
(2) Acetyl-alpha-methylfentanyl (N-[1-(1-methyl-2-phenethyl)-4-
piperidinyl]-N-phenylacetamide) 9815
(3) Acetylmethadol 9601
(4) Acryl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-
phenylacrylamide;
acryloylfentanyl) 9811
(5)(2) AH-7921 (3,4-dichloro-N-[(1-
dimethylamino)cyclohexylmethyl]benzamide) 9551
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
HB 2765 7
(6)(3) Allylprodine 9602
(7)(4) Alphacetylmethadol 9603
(except levo-alphacetylmethadol also known as levo-alpha-
acetylmethadol, levomethadyl acetate or LAAM)
(8)(5) Alphameprodine 9604
(9)(6) Alphamethadol 9605
(10) Alpha′-methyl butyryl fentanyl (2-methyl-N-(1-
phenethylpiperidin-4-yl)-N-phenylbutanamide) 9864
(11) Alpha-methylfentanyl (N-[1-(alpha-methyl-beta-phenyl)ethyl-4-
piperidyl] propionanilide; 1-(1-methyl-2-phenylethyl)-4-(N-propanilido)
piperidine) 9814
(12) Alpha-methylthiofentanyl (N-[1-methyl-2-(2-thienyl)ethyl-4-
piperidinyl]-N-phenylpropanamide) 9832
(13)(7) Benzethidine 9606
(14)(8) Betacetylmethadol 9607
(15) Beta-hydroxyfentanyl (N-[1-(2-hydroxy-2-phenethyl)-4-
piperidinyl]-N-phenylpropanamide) 9830
(16) Beta-hydroxy-3-methylfentanyl (other name: N-[1-(2-hydroxy-2-
phenethyl)-3-methyl-4-piperidinyl]-N-phenylpropanamide) 9831
(17) Beta-hydroxythiofentanyl (N-[1-[2-hydroxy-2-(thiophen-2-
yl)ethyl]piperidin-4-yl]-N-phenylpropionamide) 9836
(18)(9) Betameprodine 9608
(19)(10) Betamethadol 9609
(20) Beta-methyl fentanyl (N-phenyl-N-(1-(2-phenylpropyl)piperidin-
4-yl)propionamide; also known as β-methyl fentanyl) 9856
(21) Beta'-phenyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N, 3-
diphenylpropanamide; also known as β'-phenyl fentanyl; 3-
phenylpropanoyl fentanyl) 9842
(22)(11) Betaprodine 9611
(23)(12) Brorphine (1-(1-(1-(4-bromophenyl)ethyl)piperidin-4-yl)-1,3-
dihydro-2H-benzo[d]imidazol-2-one) 9098
(24)(13) Butonitazene (2-(2-(4-butoxybenzyl)-5-nitro-1 H -benzimidazol-1-
yl)- N,N -diethylethan-1-amine) 9751
Butyryl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-
phenylbutyramide) 9822
(25)(14) Clonitazene 9612
(26) Crotonyl fentanyl ((E)-N-(1-phenethylpiperidin-4-yl)-N-
phenylbut-2-enamide) 9844
(27) Cyclopentyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-
phenylcyclopentanecarboxamide) 9847
(28) Cyclopropyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-
phenylcyclopropanecarboxamide) 9845
(29)(15) Dextromoramide 9613
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
HB 2765 8
(30)(16) Diampromide 9615
(31)(17) Diethylthiambutene 9616
(32)(18) Difenoxin 9168
(33)(19) Dimenoxadol 9617
(34)(20) Dimepheptanol 9618
(35) 2′,5′-Dimethoxyfentanyl (N-(1-(2,5-
dimethoxyphenethyl)piperidin-4-yl)-N-phenylpropionamide) 9861
(36)(21) Dimethylthiambutene 9619
(37)(22) Dioxaphetyl butyrate 9621
(38)(23) Dipipanone 9622
(39)(24) 2-(2-(4-ethoxybenzyl)-1 H -benzimidazol-1-yl)- N,N
-diethylethan-1-amine (Other names: etodesnitazene; etazene)
9765
(25) 2-(4-ethoxybenzyl)-5-nitro-1-(2-(piperidin-1-yl)ethyl)-1 H
-benzimidazole (Other names: N -piperidinyl etonitazene; etonitazepipne)
9761
(26) 2-(4-ethoxybenzyl)-5-nitro-1-(2-(pyrrolidin-1-yl)ethyl)-1 H
-benzimidazole (Other names: N -pyrrolidino etonitazene; etonitazepyne)
9758
(27) Ethylmethylthiambutene 9623
(40)(28) Etonitazene 9624
(41)(29) Etoxeridine 9625
(42) Fentanyl carbamate (ethyl (1-phenethylpiperidin-4-yl)
(phenyl)carbamate) 9851
(43) 2′-Fluoro ortho-fluorofentanyl (N-(1-(2-
fluorophenethyl)piperidin-4-yl)-N-(2-fluorophenyl)propionamide; also
known as 2′-fluoro 2-fluorofentanyl) 9855
(44)(30) Flunitazene ( N,N -diethyl-2-(2-(4-fluorobenzyl)-5-nitro-1 H
-benzimidazol-1-yl)ethan-1-amine) 9756
Furanyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylfuran-
2-carboxamide) 9834
(45) 3-Furanyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-
phenylfuran-3-
carboxamide) 9860
(46)(31) Furethidine 9626
(47)(32) 7-hydroxymitragynine (7-OH)
(33) Hydroxypethidine 9627
(48) Isobutyryl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-
phenylisobutyramide) 9827
(49)(34) Isotonitazene (N,N-diethyl-2-(2-(4 isopropoxybenzyl)-5-nitro-
1H-benzimidazol-1-yl)ethan-1-amine; N,N-diethyl-2-[[4-(1-
methylethoxy)phenyl]methyl]-5-nitro-1 H-benzimidazole-1-ethanamine)
9614
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
HB 2765 9
(50) Isovaleryl fentanyl (3-methyl- N -(1-phenethylpiperidin-4-yl)-
N-phenylbutanamide) 9862
(51)(35) Ketobemidone 9628
(52)(36) Levomoramide 9629
(53)(37) Levophenacylmorphan 9631
(54) Meta -Fluorofentanyl (N -(3-fluorophenyl)- N -(1-
phenethylpiperidin-4-yl)propionamide) 9857
(55) Meta -Fluoroisobutyryl fentanyl ( N -(3-fluorophenyl)- N -(1-
phenethylpiperidin-4-yl)isobutyramide) 9858
(56) Methoxyacetyl fentanyl (2-methoxy-N-(1-phenethylpiperidin-4-
yl)-N-phenylacetamide) 9825
(57)(38) 2-(4-methoxybenzyl)-5-nitro-1-(2-(pyrrolidin-1-yl)ethyl)-1 H
-benzimidazole (Other names: N -pyrrolidino metonitazene;
metonitazepyne) 9762
(39) 2-Methyl AP-237 (1-(2-methyl-4-(3-phenylprop-2-en-1-
yl)piperazin-1-yl)
butan-1-one) 9664
4′-Methyl acetyl fentanyl (N-(1-(4-methylphenethyl)piperidin-4-yl)-N-
phenylacetamide) 9819
(58) 3-Methylfentanyl (N-[3-methyl-1-(2-phenylethyl)-4-piperidyl]-N-
phenylpropanamide) 9813
(59) 3-Methylthiofentanyl (N-[(3-methyl-1-(2-thienyl)ethyl-4-
piperidinyl]-N-phenylpropanamide) 9833
(60)(40) Metodesnitazene ( N,N -diethyl-2-(2-(4-methoxybenzyl)-1 H
-benzimidazol-1-yl)ethan-1-amine) 9764
(41) Metonitazene (N,N-diethyl-2-(2-(4-methoxybenzyl)-5-nitro-1H-
benzimidazol-1-yl)ethan-1-amine) 9757
(61)(42) Morpheridine 9632
(62)(43) MPPP (1-methyl-4-phenyl-4-propionoxypiperidine) 9661
(63)(44) MT-45 (1-cychohexyl-4-(1,2-diphenylethyl)piperazine)
9560
(64)(45) N- ethyl-2-(2-(4-isopropoxybenzyl)-5-nitro-1 H -benzimidazol-1-
yl)ethan-1-amine (Other name: N -desethyl isotonitazene) 9760
(46) N,N -diethyl-2-(5-nitro-2-(4-propoxybenzyl)-1 H -benzimidazol-1-
yl)ethan-1-amine (Other name: protonitazene) 9759
(47) 5-nitro-2-(4-propoxybenzyl)-1-(2-(pyrrolidin-1-yl)ethyl)-1 H
-benzimidazole (Other names: N -pyrrolidino protonitazene;
protonitazepyne) 9763
(48) Noracymethadol 9633
(65)(49) Norlevorphanol 9634
(66)(50) Normethadone 9635
(67)(51) Norpipanone 9636
(68) Ocfentanil (N-(2-fluorophenyl)-2-methoxy-N-(1-
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
HB 2765 10
phenethylpiperidin-4-yl)
acetamide) 9838
(69)(52) O-desmethyltramadol (Some trade or other names: 2-
((dimethylamino)methyl-1-(3-hydroxyphenyl)cyclohexanol;3-(2-
((dimethylamino)methyl)-1-hydroxycyclohexyl)phenol)
(70) Ortho-fluoroacryl fentanyl (N-(2-fluorophenyl)-N-(1-
phenethylpiperidin-4-yl)acrylamide) 9852
(71) Ortho-fluorobutyryl fentanyl (N-(2-fluorophenyl)-N-(1-
phenethylpiperidin-4-yl)butyramide; also known as 2-fluorobutyryl
fentanyl) 9846
(72) Ortho-fluorofentanyl (N-(2-fluorophenyl)-N-(1-
phenethylpiperidin-4-yl)propionamide; 2-fluorofentanyl) 9816
(73) Ortho -Fluorofuranyl fentanyl ( N -(2-fluorophenyl)- N -(1-
phenethylpiperidin-4-yl)furan-2-carboxamide) 9863
(74) (Ortho-fluoroisobutyryl fentanyl (N-(2-fluorophenyl)-N-(1-
phenethylpiperidin-4-yl)isobutyramide) 9853
(75) Ortho-methyl acetylfentanyl (N-(2-methylphenyl)-N-(1-
phenethylpiperidin-4-yl)acetamide; also known as 2-methyl
acetylfentanyl) 9848
(76) Ortho-methyl methoxyacetyl fentanyl (2-methoxy-N-(2-
methylphenyl)-N-(1-phenethylpiperidin-4-yl)acetamide; also known as 2-
methyl methoxyacetyl
fentanyl) 9820
(77) Para-chloroisobutyryl fentanyl (N-(4-chlorophenyl)-N-(1-
phenethylpiperidin-4-yl)isobutyramide) 9826
(78) Para-fluorobutyryl fentanyl (N-(4-fluorophenyl)-N-(1-
phenethylpiperidin-4-yl)butyramide) 9823
(79) Para-fluorofentanyl (N-(4-fluorophenyl)-N-[1-(2-phenethyl)-4-
piperidinyl]propanamide) 9812
(80) Para-fluoroisobutyryl fentanyl (N-(4-fluorophenyl)-N-(1-
phenethylpiperidin-4-yl)isobutyramide, 4-fluoroisobutyryl fentanyl)
9824
(81) Para-fluoro furanyl fentanyl (N-(4-fluorophenyl)-N-(1-
phenethylpiperidin-4-yl)furan-2-carboxamide) 9854
(82) Para-methoxybutyryl fentanyl (N-(4-methoxyphenyl)-N-(1-
phenethylpiperidin-4-yl)butyramide) 9837
(83) Para -Methoxyfuranyl fentanyl ( N -(4-methoxyphenyl)- N -(1-
phenethylpiperidin-4-yl)furan-2-carboxamide 9859
(84) para -Methylcyclopropyl fentanyl ( N -(4-methylphenyl)- N -(1-
phenethylpiperidin-4-yl)cyclopropanecarboxamide) 9865
(85) Para-methylfentanyl (N-(4-methylphenyl)-N-(1-
phenethylpiperidin-4-yl)propionamide; also known as 4-methylfentanyl)
9817
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
HB 2765 11
(86)(53) PEPAP (1-(-2-phenethyl)-4-phenyl-4-acetoxypiperidine)
9663
(87)(54) Phenadoxone 9637
(88)(55) Phenampromide 9638
(89)(56) Phenomorphan 9647
(90)(57) Phenoperidine 9641
(91) Phenyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-
phenylbenzamide; also known as benzoyl fentanyl) 9841
(92)(58) Piritramide 9642
(93)(59) Proheptazine 9643
(94)(60) Properidine 9644
(95)(61) Propiram 9649
(96)(62) Racemoramide 9645
(97) Tetrahydrofuranyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-
phenyltetrahydrofuran-2-carboxamide) 9843
(98) Thiofentanyl (N-phenyl-N-[1-(2-thienyl)ethyl-4-piperidinyl]-
propanamide) 9835
(99) Thiofuranyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-
phenylthiophene-2-carboxamide; also known as 2-thiofuranyl fentanyl;
thiophene fentanyl) 9839
(100)(63) Tilidine 9750
(101)(64) Trimeperidine 9646
(102)(65) U-47700 (3,4-dichloro-N-[2-
(dimethylamino)cyclohexyl]-N-
methylbenzamide) 9547
(103) Valeryl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-
phenylpentanamide) 9840
(104)(66) Zipeprol (1-methoxy-3-[4-(2-methoxy-2-
phenylethyl)piperazin-1-yl]-1-
phenylpropan-2-ol) 9873
(c) Any of the following opium derivatives, their salts, isomers and
salts of isomers, unless specifically excepted, whenever the existence of
these salts, isomers and salts of isomers is possible within the specific
chemical designation:
(1) Acetorphine 9319
(2) Acetyldihydrocodeine 9051
(3) Benzylmorphine 9052
(4) Codeine methylbromide 9070
(5) Codeine-N-Oxide 9053
(6) Cyprenorphine 9054
(7) Desomorphine 9055
(8) Dihydromorphine 9145
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
HB 2765 12
(9) Drotebanol 9335
(10) Etorphine (except hydrochloride salt) 9056
(11) Heroin 9200
(12) Hydromorphinol 9301
(13) Methyldesorphine 9302
(14) Methyldihydromorphine 9304
(15) Morphine methylbromide 9305
(16) Morphine methylsulfonate 9306
(17) Morphine-N-Oxide 9307
(18) Myrophine 9308
(19) Nicocodeine 9309
(20) Nicomorphine 9312
(21) Normorphine 9313
(22) Pholcodine 9314
(23) Thebacon 9315
(d) Any material, compound, mixture or preparation that contains any
quantity of the following hallucinogenic substances, their salts, isomers
and salts of isomers, unless specifically excepted, whenever the existence
of these salts, isomers and salts of isomers is possible within the specific
chemical designation:
(1) Alpha-ethyltryptamine 7249
Some trade or other names: etryptamine; Monase; α-ethyl-1H-indole-3-
ethanamine; 3-(2-aminobutyl) indole; α-ET; and AET.
(2) 4-bromo-2,5-dimethoxy-amphetamine 7391
Some trade or other names: 4-bromo-2,5-dimethoxy-alpha-
methylphenethylamine; 4-bromo-2,5-DMA.
(3) 2,5-dimethoxyamphetamine 7396
Some trade or other names: 2,5-dimethoxy-alpha-methyl-phenethylamine;
2,5-DMA.
(4) 4-methoxyamphetamine 7411
Some trade or other names: 4-methoxy-alpha-methylphene-thylamine;
paramethoxyamphetamine; PMA.
(5) 5-methoxy-3,4-methylenedioxy-amphetamine 7401
(6) 4-methyl-2,5-dimethoxy-amphetamine 7395
Some trade or other names: 4-methyl-2,5-dimethoxy-alpha-
methylphenethylamine; "DOM"; and "STP".
(7) 3,4-methylenedioxy amphetamine 7400
(8) 3,4-methylenedioxymethamphetamine (MDMA) 7405
(9) 3,4-methylenedioxy-N-ethylamphetamine (also known as N-
ethyl-alpha-methyl-3,4 (methylenedioxy) phenethylamine, N-ethyl MDA,
MDE, and MDEA) 7404
(10) N-hydroxy-3,4-methylenedioxyamphetamine (also known as N-
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
HB 2765 13
hydroxy-alpha-methyl-3,4-(methylenedioxy) phenethylamine, and N-
hydroxy MDA) 7402
(11) 3,4,5-trimethoxy amphetamine 7390
(12) Bufotenine 7433
Some trade or other names: 3-(Beta-Dimethylaminoethyl)-5-
hydroxyindole; 3-(2-dimethylaminoethyl)-5-indolol; N, N-
dimethylserotonin; 5-hydroxy-N,N-dimethyltryptamine; mappine.
(13) Diethyltryptamine 7434
Some trade or other names: N,N-Diethyltryptamine; DET.
(14) Dimethyltryptamine 7435
Some trade or other names: DMT.
(15) Ibogaine7260
Some trade or other names: 7-Ethyl-6,6 Beta,7,8,9,10,12,13-octahydro-2-
methoxy-6,9-methano-5H-pyrido[1',2':1,2]azepino[5,4-b]indole;
Tabernanthe iboga
(16) Lysergic acid diethylamide 7315
(17) Marijuana 7360
(18) Mescaline 7381
(19) Parahexyl 7374
Some trade or other names: 3-Hexyl-l-hydroxy-7,8,9,10-tetrahydro-6,6,9-
trimethyl-6H-dibenzo[b,d]pyran; Synhexyl.
(20) Peyote 7415
Meaning all parts of the plant presently classified botanically as
Lophophora williamsii Lemaire, whether growing or not, the seeds
thereof, any extract from any part of such plant, and every compound,
manufacture, salts, derivative, mixture or preparation of such plant, its
seeds or extracts.
(21) N-ethyl-3-piperidyl benzilate 7482
(22) N-methyl-3-piperidyl benzilate 7484
(23) Psilocybin 7437
(24) Psilocyn7438
Some trade or other names: Psilocin.
(25) Ethylamine analog of phencyclidine 7455
Some trade or other names: N-ethyl-1-phenyl-cyclo-hexylamine; (1-
phenylcyclohexyl)ethylamine; N-(1-phenylcyclohexyl)ethylamine;
cyclohexamine; PCE.
(26) Pyrrolidine analog of phencyclidine 7458
Some trade or other names: 1-(1-phenylcyclohexyl)-pyrrolidine; PCPy;
PHP.
(27) Thiophene analog of phencyclidine7470
Some trade or other names: 1-[1-(2-thienyl)-cyclohexyl]-piperidine; 2-
thienyl analog of phencyclidine; TPCP; TCP.
(28) 1-[1-(2-thienyl)-cyclohexyl] pyrrolidine 7473
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
HB 2765 14
Some other names: TCPy.
(29) 2,5-dimethoxy-4-ethylamphetamine 7399
Some trade or other names: DOET.
(30) Salvia divinorum or salvinorum A; all parts of the plant presently
classified botanically as salvia divinorum, whether growing or not, the
seeds thereof, any extract from any part of such plant, and every
compound, manufacture, salts, derivative, mixture or preparation of such
plant, its seeds or extracts.
(31) Datura stramonium, commonly known as gypsum weed or jimson
weed; all parts of the plant presently classified botanically as datura
stramonium, whether growing or not, the seeds thereof, any extract from
any part of such plant, and every compound, manufacture, salts, derivative,
mixture or preparation of such plant, its seeds or extracts.
(32) 1-(3-[trifluoromethylphenyl])piperazine
Some trade or other names: TFMPP.
(33) 4-Bromo-2,5-dimethoxyphenethylamine 7392
(34) 2,5-dimethoxy-4-(n)-propylthiophenethylamine (2C-T-7), its
optical isomers, salts and salts of optical isomers 7348
(35) Alpha-methyltryptamine (other name: AMT) 7432
(36) 5-methoxy-N,N-diisopropyltryptamine (5-MeO-DIPT), its
isomers, salts and salts of isomers 7439
(37) 2-(2,5-Dimethoxy-4-ethylphenyl)ethanamine (2C-E) 7509
(38) 2-(2,5-Dimethoxy-4-methylphenyl)ethanamine (2C-D)
7508
(39) 2-(4-Chloro-2,5-dimethoxyphenyl)ethanamine (2C-C)
7519
(40) 2-(4-Iodo-2,5-dimethoxyphenyl)ethanamine (2C-I) 7518
(41) 2-[4-(Ethylthio)-2,5-dimethoxyphenyl]ethanamine (2C-T-2)
7385
(42) 2-[4-(Isopropylthio)-2,5-dimethoxyphenyl]
ethanamine (2C-T-4) 7532
(43) 2-(2,5-Dimethoxyphenyl)ethanamine (2C-H) 7517
(44) 2-(2,5-Dimethoxy-4-nitrophenyl)ethanamine (2C-N) 7521
(45) 2-(2,5-Dimethoxy-4-(n)-propylphenyl)ethanamine (2C-P)
7524
(46) 5–methoxy–N,N–dimethyltryptamine (5–MeO–DMT)
7431
Some trade or other names: 5–methoxy–3–[2–(dimethylamino)
ethyl]indole.
(47) 2–(4–iodo–2,5–dimethoxyphenyl)–N–(2–
methoxybenzyl)ethanamine 7538
Some trade or other names: 25I–NBOMe; 2C–I–NBOMe; 25I; Cimbi–5.
(48) 2–(4–chloro–2,5–dimethoxyphenyl)–N–(2–
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
HB 2765 15
methoxybenzyl)ethanamine 7537
Some trade or other names: 25C–NBOMe; 2C–C–NBOMe; 25C; Cimbi–
82.
(49) 2–(4–bromo–2,5–dimethoxyphenyl)–N–(2–
methoxybenzyl)ethanamine 7536
Some trade or other names: 25B–NBOMe; 2C–B–NBOMe; 25B; Cimbi–
36.
(50) 2-(2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine
Some trade or other names: 25H-NBOMe.
(51) 2-(2,5-dimethoxy-4-methylphenyl)-N-(2-
methoxybenzyl)ethanamine
Some trade or other names: 25D-NBOMe; 2C-D-NBOMe.
(52) 2-(2,5-dimethoxy-4-nitrophenyl)-N-(2-
methoxybenzyl)ethanamine
Some trade or other names: 25N-NBOMe, 2C-N-NBOMe.
(53) 1-(5-fluoropentyl)-N-(2-phenylpropan-2-yl)-1 H-pyrrolo[2,3-
b]pyridine-3-carboxamide (5F-CUMYL-P7AICA) 7085
(54) 2-(ethylamino)-2-(3-methoxyphenyl)cyclohexan-1-one (other
names: methoxetamine, MXE) 7286
(55) 1-(4-methoxyphenyl)-N-methylpropan-2-amine (other names:
para-methoxymethamphetamine, PMMA) 1245
(e) Any material, compound, mixture or preparation that contains any
quantity of the following substances having a depressant effect on the
central nervous system, including its salts, isomers, and salts of isomers
whenever the existence of such salts, isomers, and salts of isomers is
possible within the specific chemical designation:
(1) Etizolam 2780
Some trade or other names: (4-(2-chlorophenyl)-2-ethyl-9-methyl-6H-
thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine)
(2) Mecloqualone 2572
(3) Methaqualone 2565
(4) Gamma hydroxybutyric acid 2010
(5) 8-chloro-6-(2-fluorophenyl)-1-methyl-4H-benzo[f]
[1,2,4]triazolo[4,3-a][1,4]diazepine, its salts, isomers, and salts of isomers
(other name: flualprazolam) 2785
(6) 6-(2-chlorophenyl)-1-methyl-8-nitro-4H-benzo[f]
[1,2,4]triazolo[4,3-a][1,4]diazepine, its salts, isomers, and salts of isomers
(other name: clonazolam) 2786
(7) 8-bromo-6-(2-fluorophenyl)-1-methyl-4H-benzo[f]
[1,2,4]triazolo[4,3-a][1,4]diazepine, its salts, isomers, and salts of isomers
(other name: flubromazolam) 2788
(8) 7-chloro-5-(2-chlorophenyl)-1-methyl-1,3-dihydro-2H-benzo[e]
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
HB 2765 16
[1,4]diazepin-2-one, its salts, isomers, and salts of isomers (other name:
diclazepam) 2789
(f) Unless specifically excepted or unless listed in another schedule,
any material, compound, mixture or preparation that contains any quantity
of the following substances having a stimulant effect on the central
nervous system, including its salts, isomers and salts of isomers:
(1) Aminorex 1585
Some other names: Aminoxaphen 2-amino-5-phenyl-2-oxazoline or 4,5-
dihydro-5-phenyl-2-oxazolamine
(2) Fenethylline 1503
(3) N-ethylamphetamine 1475
(4) (+)cis-4-methylaminorex ((+)cis-4,5-dihydro-4-methyl-5-phenyl-
2-oxazolamine) 1590
(5) N,N-dimethylamphetamine (also known as N,N-alpha-trimethyl-
benzeneethanamine; N,N-alpha-trimethylphenethylamine) 1480
(6) Cathinone (some other names: 2-amino-1-phenol-1-propanone,
alpha-amino propiophenone, 2-amino propiophenone and norphedrone)
1235
(7) Substituted cathinones
Any compound, except bupropion or compounds listed under a different
schedule, structurally derived from 2–aminopropan–1–one by substitution
at the 1-position with either phenyl, naphthyl, or thiophene ring systems,
whether or not the compound is further modified in any of the following
ways:
(A) By substitution in the ring system to any extent with alkyl,
alkylenedioxy, alkoxy, haloalkyl, hydroxyl, or halide substituents, whether
or not further substituted in the ring system by one or more other univalent
substituents;
(B) by substitution at the 3-position with an acyclic alkyl
substituent;
(C) by substitution at the 2-amino nitrogen atom with alkyl,
dialkyl, benzyl, or methoxybenzyl groups; or
(D) by inclusion of the 2-amino nitrogen atom in a cyclic
structure.
(8) N-benzylpiperazine (other names: BZP, 1-benzylpiprazine)
7493
(9) Methiopropamine
(N-methyl-1-(thiophen-2-yl)propan-2-amine) 1478
(10) 4,4′-Dimethylaminorex (4,4′-DMAR; 4,5-dihydro-4-methyl-5-(4-
methylphenyl)-2-oxazolamine; 4-methyl-5-(4-methylphenyl)-4,5-dihydro-
1,3-oxazol-2-amine) 1595
(11) Amineptine (7-[(10,11-dihydro-5 H-dibenzo[a,d]cyclohepten-5-
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
HB 2765 17
yl)amino]heptanoic acid) 1219
(12) Mesocarb (N-phenyl-N ′-(3-(1-phenylpropan-2-yl)-1,2,3-
oxadiazol-3-ium-5-yl)carbamimidate) 1227
(13) Ethylphenidate (ethyl 2-phenyl-2-(piperidin-2-yl)acetate)
1727
(g) Any material, compound, mixture or preparation that contains any
quantity of the following substances:
(1) N-[1-benzyl-4-piperidyl]-N-phenylpropanamide (benzylfentanyl),
its optical isomers, salts and salts of isomers
(2) N-[1-(2-thienyl)methyl-4-piperidyl]-N-phenylpropanamide
(thenylfentanyl), its optical isomers, salts and salts of isomers
(3) Tianeptine, its optical isomers, salts and salts of isomers
(h) Any of the following cannabinoids, their salts, isomers and salts
of isomers, unless specifically excepted, whenever the existence of these
salts, isomers and salts of isomers is possible within the specific chemical
designation:
(1) Tetrahydrocannabinols 7370
Meaning tetrahydrocannabinols naturally contained in a plant of the genus
Cannabis (cannabis plant), as well as synthetic equivalents of the
substances contained in the plant, or in the resinous extractives of
Cannabis, sp. and/or synthetic substances, derivatives, and their isomers
with similar chemical structure and pharmacological activity such as the
following: Delta 1 9 cis or trans tetrahydrocannabinol, and their optical
isomers Delta 6 8 cis or trans tetrahydrocannabinol, and their optical
isomers Delta 3,4 6a,10a cis or trans tetrahydrocannabinol, and its optical
isomers (Since nomenclature of these substances is not internationally
standardized, compounds of these structures, regardless of numerical
designation of atomic positions covered.), except tetrahydrocannabinols in
any of the following:
(A) Industrial hemp, as defined in K.S.A. 2-3901, and
amendments thereto;
(B) solid waste, as defined in K.S.A. 65-3402, and amendments
thereto, and hazardous waste, as defined in K.S.A. 65-3430, and
amendments thereto, if such waste is the result of the cultivation,
production or processing of industrial hemp, as defined in K.S.A. 2-3901,
and amendments thereto, and such waste contains a delta-9
tetrahydrocannabinol concentration of not more than 0.3%; or
(C) hemp products, as defined in K.S.A. 2-3901, and amendments
thereto, unless otherwise deemed unlawful pursuant to K.S.A. 2-3908, and
amendments thereto.
For the purposes of this subsection, the dibenzopyran system is
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
HB 2765 18
the numbering convention used to identify the carbon atoms of the
chemical structure.
(2) Naphthylmethylindoles
Any compound containing a 1H-indol-3-yl-(1-naphthyl)methane structure
with substitution at the nitrogen atom of the indole group by an alkyl,
haloalkyl, cyanoalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, benzyl,
1-(N-methyl-2-piperidinyl)methyl or 2-(4-morpholinyl)ethyl group
whether or not further substituted on the indole group to any extent and
whether or not substituted on the benzyl or naphthyl ring to any extent.
(3) Naphthoylpyrroles
Any compound containing a 3-(1-naphthoyl)pyrrole structure with
substitution at the nitrogen atom of the pyrrole group by an alkyl,
haloalkyl, cyanoalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, benzyl,
1-(N-methyl-2-piperidinyl)methyl or 2-(4-morpholinyl)ethyl group
whether or not further substituted on the pyrrole group to any extent,
whether or not substituted on the benzyl or naphthyl ring to any extent.
(4) Naphthylmethylindenes
Any compound containing a naphthylmethylindene structure with
substitution at the 3-position of the indene group by an alkyl, haloalkyl,
cyanoalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, benzyl, 1-(N-
methyl-2-piperidinyl)methyl or 2-(4-morpholinyl)ethyl group whether or
not further substituted on the indene group to any extent, whether or not
substituted on the benzyl or naphthyl ring to any extent.
(5) Cyclohexylphenols
Any compound containing a 2-(3-hydroxycyclohexyl)phenol structure
with substitution at the 5-position of the phenolic ring by an alkyl,
haloalkyl, cyanoalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-
methyl-2-piperidinyl)methyl or 2-(4-morpholinyl)ethyl group whether or
not substituted on the cyclohexyl ring to any extent.
(6) 2,3-Dihydro-5-methyl-3-(4-morpholinylmethyl)pyrrolo[1,2,3-de]-
1,4-benzoxazin-6-yl]-1-napthalenylmethanone.
Some trade or other names: WIN 55,212-2.
(7) 9-(hydroxymethyl)-6, 6-dimethyl-3-(2-methyloctan-2-yl)-
6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol
Some trade or other names: HU-210, HU-211.
(8) Indole-3-carboxylate esters
Any compound containing a 1H-indole-3-carboxylate ester structure with
the ester oxygen bearing a naphthyl, quinolinyl, isoquinolinyl or
adamantyl group and substitution at the 1 position of the indole ring by an
alkyl, haloalkyl, cyanoalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl,
benzyl, 1-(N-methyl-2-piperidinyl)methyl or 2-(4-morpholinyl)ethyl
group, whether or not further substituted on the indole ring to any extent
and whether or not substituted on the naphthyl, quinolinyl, isoquinolinyl,
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
HB 2765 19
adamantyl or benzyl groups to any extent.
(9) Indazole-3-carboxamides
Any compound containing a 1H-indazole-3-carboxamide structure with
substitution at the nitrogen of the carboxamide by a naphthyl, quinolinyl,
isoquinolinyl, adamantyl, benzyl, 1-amino-1-oxoalkan-2-yl or 1-alkoxy-1-
oxoalkan-2-yl group and substitution at the 1 position of the indazole ring
by an alkyl, haloalkyl, cyanoalkyl, alkenyl, cycloalkylmethyl,
cycloalkylethyl, benzyl, 1-(N-methyl-2-piperidinyl)methyl, or 2-(4-
morpholinyl)ethyl group, whether or not further substituted on the
indazole ring to any extent and whether or not substituted on the naphthyl,
quinolinyl, isoquinolinyl, adamantyl, 1-amino-1-oxoalkan-2-yl, 1-alkoxy-
1-oxoalkan-2-yl or benzyl groups to any extent.
(10) Indole-3-carboxamides
Any compound containing a 1H-indole-3-carboxamide structure with
substitution at the nitrogen of the carboxamide by a naphthyl, quinolinyl,
isoquinolinyl, adamantyl, benzyl, 1-amino-1-oxoalkan-2-yl or 1-alkoxy-1-
oxoalkan-2-yl group and substitution at the 1 position of the indole ring by
an alkyl, haloalkyl, cyanoalkyl, alkenyl, cycloalkylmethyl,
cycloalkylethyl, benzyl, 1-(N-methyl-2-piperidinyl)methyl, or 2-(4-
morpholinyl)ethyl group, whether or not further substituted on the indole
ring to any extent and whether or not further substituted on the naphthyl,
quinolinyl, isoquinolinyl, adamantyl, 1-amino-1-oxoalkan-2-yl, 1-alkoxy-
1-oxoalkan-2-yl or benzyl groups to any extent.
(11) (1H-indazol-3-yl)methanones
Any compound containing a (1H-indazol-3-yl)methanone structure with
the carbonyl carbon bearing a naphthyl group and substitution at the 1
position of the indazole ring by an alkyl, haloalkyl, alkenyl,
cycloalkylmethyl, cycloalkylethyl, benzyl, 1-(N-methyl-2-
piperidinyl)methyl, or 2-(4-morpholinyl)ethyl group, whether or not
further substituted on the indazole ring to any extent and whether or not
substituted on the naphthyl or benzyl groups to any extent.
(12) (1H-indol-3-yl)methanones
Any compound containing a (1H-indol-3-yl)methanone structure with the
carbonyl carbon bearing a naphthyl, quinolinyl, isoquinolinyl, adamantyl,
phenyl, benzyl or tetramethylcyclopropyl group and substitution at the 1
position of the indole ring by an alkyl,haloalkyl, cyanoalkyl, alkenyl,
cycloalkylmethyl, cycloalkylethyl, benzyl, 1-(N-methyl-2-
piperidinyl)methyl, 2-(4-morpholinyl)ethyl, 1-(N-methyl-2-
pyrrolidinyl)methyl, 1-(N-methyl-3-morpholinyl)methyl, or
tetrahydropyranylmethyl group, whether or not further substituted on the
indole ring to any extent and whether or not substituted on the naphthyl,
quinolinyl, isoquinolinyl, adamantyl, phenyl, benzyl or
tetramethylcyclopropyl groups to any extent.
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
HB 2765 20
(13) Hexahydrocannabinol (HHC)
(14) 5-Pentyl-2-(2-phenylpropan-2-yl)pyrido[4,3-b]indol-1-one, its
optical and geometric isomers, salts and salts of isomers (Some trade or
ther names: CUMYL–PEGACLONE; SGT–151) 7093
(i) (1) Unless specifically exempted or unless listed in schedules II
through V of the uniform controlled substances act, any material,
compound, mixture or preparation that contains any quantity of a
fentanyl-related substance or that contains the salts, isomers and salts of
isomers of a fentanyl-related substance whenever the existence of such
salts, isomers and salts of isomers is possible within the specific chemical
designation.
(2) "Fentanyl-related substance" means any substance that is
structurally related to fentanyl by one or more of the following
modifications:
(A) Replacement of the phenyl portion of the phenethyl group by any
monocycle, whether or not further substituted in or on the monocycle;
(B) substitution in or on the phenethyl group (or replacement as
described in sub-paragraph (A)) with alkyl, alkenyl, alkoxyl, hydroxyl,
halo, haloalkyl, amino or nitro groups;
(C) substitution in or on the piperidine ring with alkyl, alkenyl,
alkoxyl, ester, ether, hydroxyl, halo, haloalkyl, amino or nitro groups;
(D) replacement of the aniline ring with any aromatic monocycle
whether or not further substituted in or on the aromatic monocycle; or
(E) replacement of the N-propionyl group by another acyl group.
Sec. 3. K.S.A. 65-4109 is hereby amended to read as follows: 65-
4109. (a) The controlled substances listed in this section are included in
schedule III and the number set forth opposite each drug or substance is
the DEA controlled substances code which has been assigned to it.
(b) Unless listed in another schedule, any material, compound,
mixture, or preparation which contains any quantity of the following
substances having a potential for abuse associated with a depressant effect
on the central nervous system:
(1) Any compound, mixture or preparation containing:
(A) Amobarbital...........................................................................2126
(B) Secobarbital...........................................................................2316
(C) Pentobarbital......................................................................... 2271
or any salt thereof and one or more other active medicinal
ingredients which are not listed in any schedule.
(2) Any suppository dosage form containing:
(A) Amobarbital...........................................................................2126
(B) Secobarbital...........................................................................2316
(C) Pentobarbital......................................................................... 2271
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
HB 2765 21
or any salt of any of these drugs and approved by the Food and
Drug Administration for marketing only as a suppository.
(3) Any substance which contains any quantity of a derivative of
barbituric acid, or any salt of a derivative of barbituric acid, except
those substances which are specifically listed in other schedules. 2100
(4) Chlorhexadol................................................................................. 2510
(5) Lysergic acid..................................................................................7300
(6) Lysergic acid amide....................................................................... 7310
(7) Methyprylon.................................................................................. 2575
(8) Sulfondiethylmethane....................................................................2600
(9) Sulfonethylmethane.......................................................................2605
(10) Sulfonmethane...............................................................................2610
(11) Tiletamine and zolazepam or any salt thereof............................... 7295
Some trade or other names for a tiletamine-zolazepam combination
product: Telazol
Some trade or other names for tiletamine: 2-(ethylamino)-2-(2-
thienyl)-cyclohexanone
Some trade or other names for zolazepam: 4-(2-fluorophenyl)-6,8-
dihydro-1,3,8-trimethylpyrazolo-[3,4-e][1,4]-diazepin-7(1H)-one,
flupyrazapon
(12) Ketamine, its salts, isomers, and salts of isomers..........................7285
Some other names for ketamine: (±)-2-(2-chlorophenyl)-2-
(methylamino)-cyclohexanone
(13) Gamma hydroxybutyric acid, any salt, hydroxybutyric compound,
derivative or preparation of gamma hydroxybutyric acid contained in
a drug product for which an application has been approved under
section 505 of the federal food, drug and cosmetic act
(14) Embutramide................................................................................. 2020
(15) Perampanel, its salts, isomers, and salts of isomers...................... 2261
Some other names for perampanel: 2-(2-oxo-1-phenyl-5-pyridin-2-
yl-1,2 dihydropyridin-3-yl) benzonitrile
(c) Nalorphine................................................................................. 9400
(d) Any material, compound, mixture or preparation containing any
of the following narcotic drugs or any salts calculated as the free
anhydrous base or alkaloid, in limited quantities as set forth below:
(1) Not more than 1.8 grams of codeine or any of its salts per 100
milliliters or not more than 90 milligrams per dosage unit with an
equal or greater quantity of an isoquinoline alkaloid of opium.....9803
(2) not more than 1.8 grams of codeine or any of its salts per 100
milliliters or not more than 90 milligrams per dosage unit with one or
more active, nonnarcotic ingredients in recognized therapeutic
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
HB 2765 22
amounts..........................................................................................9804
(3) not more than 1.8 grams of dihydrocodeine or any of its salts per 100
milliliters or not more than 90 milligrams per dosage unit with one or
more active, nonnarcotic ingredients in recognized therapeutic
amounts..........................................................................................9807
(4) not more than 300 milligrams of ethylmorphine or any of its salts per
100 milliliters or not more than 15 milligrams per dosage unit with
one or more active, nonnarcotic ingredients in recognized therapeutic
amounts..........................................................................................9808
(5) not more than 500 milligrams of opium per 100 milliliters or per 100
grams or not more than 25 milligrams per dosage unit with one or
more active, nonnarcotic ingredients in recognized therapeutic
amounts..........................................................................................9809
(6) not more than 50 milligrams of morphine or any of its salts per 100
milliliters or per 100 grams with one or more active, nonnarcotic
ingredients in recognized therapeutic amounts............................. 9810
(7) any material, compound, mixture or preparation containing any of the
following narcotic drugs or their salts, as set forth below:
(A) Buprenorphine.......................................................................9064
(e) Unless specifically excepted or unless listed in another schedule,
any material, compound, mixture or preparation which contains any
quantity of the following substances having a stimulant effect on the
central nervous system, including its salts, isomers (whether optical,
position or geometric) and salts of such isomers whenever the existence of
such salts, isomers and salts of isomers is possible within the specific
chemical designation:
(1) Those compounds, mixtures or preparations in dosage unit form
containing any stimulant substance listed in schedule II, which
compounds, mixtures or preparations were listed on August 25, 1971,
as excepted compounds under section 308.32 of title 21 of the code
of federal regulations, and any other drug of the quantitive
composition shown in that list for those drugs or which is the same,
except that it contains a lesser quantity of controlled substances..1405
(2) Benzphetamine.............................................................................. 1228
(3) Chlorphentermine.......................................................................... 1645
(4) Chlortermine..................................................................................1647
(5) Phendimetrazine............................................................................ 1615
(f) Anabolic steroids........................................................................4000
"Anabolic steroid" means any drug or hormonal substance, chemically
and pharmacologically related to testosterone (other than estrogens,
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
HB 2765 23
progestins, and corticosteroids) that promotes muscle growth, and
includes:
(1) 3β,17-dihydroxy-5a-androstane
(2) 3α,17β-dihydroxy-5a-androstane
(3) 5α-androstan-3,17-dione
(4) 1-androstenediol (3β,17β-dihydroxy-5α-androst-1-ene)
(5) 1-androstenediol (3α,17β-dihydroxy-5α-androst-1-ene)
(6) 4-androstenediol (3β,17β-dihydroxy-androst-4-ene)
(7) 5-androstenediol (3β,17β-dihydroxy-androst-5-ene)
(8) 1-androstenedione ([5α]-androst-1-en-3,17-dione)
(9) 4-androstenedione (androst-4-en-3,17-dione)
(10) 5-androstenedione (androst-5-en-3,17-dione)
(11) bolasterone (7α,17α-dimethyl-17β-hydroxyandrost-4-en-3-one)
(12) boldenone (17β-hydroxyandrost-1,4-diene-3-one)
(13) boldione (androsta-1,4-diene-3,17-dione)
(14) calusterone (7β,17α-dimethyl-17β-hydroxyandrost-4-en-3-one)
(15) clostebol (4-chloro-17β-hydroxyandrost-4-en-3-one)
(16) dehydrochloromethyltestosterone (4-chloro-17β-hydroxy-17α-
methyl-androst-1,4-dien-3-one)
(17) desoxymethyltestosterone (17α-methyl-5α-androst-2-en-17β-ol) (also
known as "madol")
(18) Δ1-dihydrotestosterone (17β-hydroxy-5α-androst-1-en-3-one) (also
known as "1-testosterone")
(19) 4-dihydrotestosterone (17β-hydroxy-androstan-3-one)
(20) drostanolone (17β-hydroxy-2α-methyl-5α-androstan-3-one)
(21) ethylestrenol (17α-ethyl-17β-hydroxyestr-4-ene)
(22) fluoxymesterone (9-fluoro-17α-methyl-11β,17β-dihydroxyandrost-4-
en-3-one)
(23) formebolone (2-formyl-17α-methyl-11α,17β-dihydroxyandrost-1,4-
dien-3-one)
(24) furazabol (17α-methyl-17β-hydroxyandrostano[2,3-c]-furazan)
(25) 13β-ethyl-17β-hydroxygon-4-en-3-one
(26) 4-hydroxytestosterone (4,17β-dihydroxy-androst-4-en-3-one)
(27) 4-hydroxy-19-nortestosterone (4,17β-dihydroxy-estr-4-en-3-one)
(28) mestanolone (17α-methyl-17β-hydroxy-5-androstan-3-one)
(29) mesterolone (1α-methyl-17β-hydroxy-[5α]-androstan-3-one)
(30) methandienone (17α-methyl-17β-hydroxyandrost-1,4-dien-3-one)
(31) methandriol (17α-methyl-3β,17β-dihydroxyandrost-5-ene)
(32) methasterone (2α,17α-dimethyl-5α-androstan-17β-ol-3-one)
(33) methenolone (1-methyl-17β-hydroxy-5α-androst-1-en-3-one)
(34) 17α-methyl-3β,17β-dihydroxy-5a-androstane
(35) 17α-methyl-3α,17β-dihydroxy-5a-androstane
(36) 17α-methyl-3β,17β-dihydroxyandrost-4-ene
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
HB 2765 24
(37) 17α-methyl-4-hydroxynandrolone (17α-methyl-4-hydroxy-17β-
hydroxyestr-4-en-3-one)
(38) methyldienolone (17α-methyl-17β-hydroxyestra-4,9(10)-dien-3-one)
(39) methyltrienolone (17α-methyl-17β-hydroxyestra-4,9,11-trien-3-one)
(40) methyltestosterone (17α-methyl-17β-hydroxyandrost-4-en-3-one)
(41) mibolerone (7α,17α-dimethyl-17β-hydroxyestr-4-en-3-one)
(42) 17α-methyl-Δ1-dihydrotestosterone (17β-hydroxy-17α-methyl-5α-
androst-1-en-3-one) (also known as "17-α-methyl-1-testosterone")
(43) nandrolone (17β-hydroxyestr-4-en-3-one)
(44) 19-nor-4-androstenediol (3β, 17β-dihydroxyestr-4-ene)
(45) 19-nor-4-androstenediol (3α, 17β-dihydroxyestr-4-ene)
(46) 19-nor-5-androstenediol (3β, 17β-dihydroxyestr-5-ene)
(47) 19-nor-5-androstenediol (3α, 17β-dihydroxyestr-5-ene)
(48) 19-nor-4,9(10)-androstadienedione (estra-4,9(10)-diene-3,17-dione)
(49) 19-nor-4-androstenedione (estr-4-en-3,17-dione)
(50) 19-nor-5-androstenedione (estr-5-en-3,17-dione)
(51) norbolethone (13β, 17α-diethyl-17β-hydroxygon-4-en-3-one)
(52) norclostebol (4-chloro-17β-hydroxyestr-4-en-3-one)
(53) norethandrolone (17α-ethyl-17β-hydroxyestr-4-en-3-one)
(54) normethandrolone (17α-methyl-17β-hydroxyestr-4-en-3-one)
(55) oxandrolone (17α-methyl-17β-hydroxy-2-oxa-[5α]-androstan-3-one)
(56) oxymesterone (17α-methyl-4,17β-dihydroxyandrost-4-en-3-one)
(57) oxymetholone (17α-methyl-2-hydroxymethylene-17β-hydroxy-[5α]-
androstan-3-one)
(58) prostanozol (17β-hydroxy-5α-androstano[3,2-c]pyrazole)
(59) stanozolol (17α-methyl-17β-hydroxy-[5α]-androst-2-eno[3,2-c]-
pyrazole)
(60) stenbolone (17β-hydroxy-2-methyl-[5α]-androst-1-en-3-one)
(61) testolactone (13-hydroxy-3-oxo-13,17-secoandrosta-1,4-dien-17-oic
acid lactone)
(62) testosterone (17β-hydroxyandrost-4-en-3-one)
(63) tetrahydrogestrinone (13β, 17α-diethyl-17β-hydroxygon-4,9,11-trien-
3-one)
(64) trenbolone (17β-hydroxyestr-4,9,11-trien-3-one)
(65) 5α-androstan-3,6,17-trione;
(66) 6-bromo-androsta-1,4-diene-3,17-dione;
(67) 6-bromo-androstan-3,17-dione;
(68) 4-chloro-17α-methyl-androsta-1,4-diene-3,17β-diol;
(69) 4-chloro-17α-methyl-androst-4-ene-3β,17β-diol;
(70) 4-chloro-17α-methyl-17β-hydroxy-androst-4-en-3-one;
(71) 4-chloro-17α-methyl-17β-hydroxy-androst-4-ene-3,11-dione;
(72) 2α,17α-dimethyl-17β-hydroxy-5β-androstan-3-one;
(73) 2α,3α-epithio-17α-methyl-5α-androstan-17β-ol;
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
HB 2765 25
(74) estra-4,9,11-triene-3,17-dione;
(75) [3,2-c]furazan-5α-androstan-17β-ol;
(76) 18a-homo-3-hydroxy-estra-2,5(10)-dien-17-one;
(77) 4-hydroxy-androst-4-ene-3,17-dione;
(78) 17β-hydroxy-androstano[2,3-d]isoxazole;
(79) 17β-hydroxy-androstano[3,2-c]isoxazole;
(80) 3β-hydroxy-estra-4,9,11-triene-17-one;
(81) 17α-methyl-androsta-1,4-diene-3,17β-diol;
(82) 17α-methyl-5α-androstan-17β-ol;
(83) 17α-methyl-androstan-3-hydroxyimine-17β-ol;
(84) 6α-methyl-androst-4-ene-3,17-dione;
(85) 17α-methyl-androst-2-ene-3,17β-diol;
(86) [3,2-c]pyrazole-androst-4-en-17β-ol;
(87) any salt, ester, or isomer of a drug or substance described or listed in
this paragraph, if that salt, ester, or isomer promotes muscle growth.
(A) Except as provided in (B), such term does not include an anabolic
steroid which is expressly intended for administration through
implants to cattle or other nonhuman species and which has been
approved by the United States' secretary of health and human
services for such administration.
(B) If any person prescribes, dispenses or distributes such steroid for
human use, such person shall be considered to have prescribed,
dispensed or distributed an anabolic steroid within the meaning of
this subsection (f).
(g) Any material, compound, mixture or preparation which contains
any quantity of the following hallucinogenic substance, its salts, isomers
and salts of isomers, unless specifically excepted, whenever the existence
of these salts, isomers and salts of isomers is possible within the specific
chemical designation:
(1) Dronabinol (synthetic) in sesame oil and encapsulated in a soft
gelatin capsule in a United States food and drug administration
approved product........................................................................... 7369
Some other names for dronabinol: (6aR-trans)-6a,7,8,10a-tetrahydro-
6-6-9-trimethyl-3-pentyl-6H-dibenzo(b,d)pyran-1-0l, or (-)-delta-9-
(trans)-tetrahydrocannabinol.
(h) The board may except by rule any compound, mixture or
preparation containing any stimulant or depressant substance listed in
subsection (b) from the application of all or any part of this act if the
compound, mixture or preparation contains one or more active medicinal
ingredients not having a stimulant or depressant effect on the central
nervous system and if the admixtures are included therein in combinations,
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
HB 2765 26
quantity, proportion or concentration that vitiate the potential for abuse of
the substances which have a stimulant or depressant effect on the central
nervous system.
Sec. 4. K.S.A. 2025 Supp. 65-4111 is hereby amended to read as
follows: 65-4111. (a) The controlled substances listed in this section are
included in schedule IV and the number set forth opposite each drug or
substance is the DEA controlled substances code that has been assigned to
it.
(b) Any material, compound, mixture or preparation that contains any
quantity of the following substances including its salts, isomers and salts
of isomers whenever the existence of such salts, isomers and salts of
isomers is possible within the specific chemical designation and having a
potential for abuse associated with a depressant effect on the central
nervous system:
(1) Alprazolam.............................................................................. 2882
(2) Barbital.................................................................................... 2145
(3) Brexanolone.............................................................................2400
(4) Bromazepam ...........................................................................2748
(5) Camazepam............................................................................. 2749
(6) Carisoprodol............................................................................ 8192
(7) Chloral betaine.........................................................................2460
(8) Chloral hydrate........................................................................ 2465
(9) Chlordiazepoxide.....................................................................2744
(10) Clobazam.................................................................................2751
(11) Clonazepam............................................................................. 2737
(12) Clorazepate.............................................................................. 2768
(13) Clotiazepam.............................................................................2752
(14) Cloxazolam..............................................................................2753
(15) Daridorexant............................................................................ 2410
(16) Delorazepam............................................................................2754
(17) Diazepam.................................................................................2765
(18) Dichloralphenazone.................................................................2467
(19) Estazolam.................................................................................2756
(20) Ethchlorvynol.......................................................................... 2540
(21) Ethinamate...............................................................................2545
(22) Ethyl loflazepate......................................................................2758
(23) Fludiazepam.............................................................................2759
(24) Flunitrazepam.......................................................................... 2763
(25) Flurazepam.............................................................................. 2767
(26) Fospropofol..............................................................................2138
(27) Halazepam............................................................................... 2762
(28) Haloxazolam............................................................................2771
(29) Ketazolam................................................................................2772
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
HB 2765 27
(30) Lemborexant............................................................................2245
(31) Loprazolam..............................................................................2773
(32) Lorazepam............................................................................... 2885
(33) Lormetazepam......................................................................... 2774
(34) Mebutamate............................................................................. 2800
(35) Medazepam..............................................................................2836
(36) Meprobamate...........................................................................2820
(37) Methohexital............................................................................2264
(38) Methylphenobarbital (mephobarbital).....................................2250
(39) Midazolam...............................................................................2884
(40) Nimetazepam...........................................................................2837
(41) Nitrazepam...............................................................................2834
(42) Nordiazepam............................................................................2838
(43) Oxazepam................................................................................ 2835
(44) Oxazolam.................................................................................2839
(45) Paraldehyde............................................................................. 2585
(46) Petrichloral...............................................................................2591
(47) Phenobarbital...........................................................................2285
(48) Pinazepam................................................................................2883
(49) Prazepam................................................................................. 2764
(50) Quazepam................................................................................ 2881
(51) Remimazolam..........................................................................2846
(52) Temazepam..............................................................................2925
(53) Tetrazepam...............................................................................2886
(54) Triazolam.................................................................................2887
(55) Zolpidem..................................................................................2783
(56) Zaleplon...................................................................................2781
(57) Zopiclone.................................................................................2784
(58) Alfaxalone............................................................................... 2731
(59) Suvorexant...............................................................................2223
(60) Zuranolone.............................................................................. 2420
(c) Any material, compound, mixture or preparation that contains any
quantity of lorcaserin (1625), including its salts, isomers and salts of such
isomers, whenever the existence of such salts, isomers and salts of isomers
is possible (21 U.S.C. § 812; 21 C.F.R. § 1308.14).
(d) Unless specifically excepted or unless listed in another schedule,
any material, compound, mixture or preparation that contains any quantity
of the following substances having a stimulant effect on the central
nervous system, including its salts, isomers (whether optical, position or
geometric) and salts of such isomers whenever the existence of such salts,
isomers and salts of isomers is possible within the specific chemical
designation:
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
HB 2765 28
(1) Cathine ((+)-norpseudoephedrine).......................................... 1230
(2) Diethylpropion.........................................................................1610
(3) Fencamfamin........................................................................... 1760
(4) Fenproporex.............................................................................1575
(5) Mazindol..................................................................................1605
(6) Mefenorex................................................................................1580
(7) Pemoline (including organometallic complexes and chelates
thereof).....................................................................................1530
(8) Phentermine.............................................................................1640
The provisions of subsection (d)(8) shall expire on the date
phentermine and its salts and isomers are removed from schedule IV of the
federal controlled substances act (21 U.S.C. § 812; 21 C.F.R. § 1308.14).
(9) Pipradrol.................................................................................. 1750
(10) Serdexmethylphenidate........................................................... 1729
(11) SPA((-)-1-dimethylamino-1, 2-diphenylethane)......................1635
(12) Sibutramine..............................................................................1675
(13) Solriamfetol (2-amino-3-phenylpropyl carbamate;
benzenepropanol, beta-amino-, carbamate (ester))..................1650
(14) MondafinilModafinil............................................................... 1680
(e) Unless specifically excepted or unless listed in another schedule,
any material, compound, mixture or preparation that contains any quantity
of the following, including salts thereof:
(1) Pentazocine..............................................................................9709
(2) Butorphanol (including its optical isomers)............................ 9720
(3) Eluxadoline (5-[[[(2S)-2-amino-3-[4-aminocarbonyl)-2,6-
dimethylphenyl]-1-oxopropyl][(1S)-1-(4-phenyl-1H-imidazol-2-
yl)ethyl]amino]methyl]-2-methoxybenzoic acid) (including its
optical isomers) and its salts, isomers, and salts of isomers....9725
(f) Unless specifically excepted or unless listed in another schedule,
any material, compound, mixture or preparation containing any of the
following narcotic drugs, or their salts calculated as the free anhydrous
base or alkaloid, in limited quantities as set forth below:
(1) Not more than 1 milligram of difenoxin and not less than 25
micrograms of atropine sulfate per dosage unit.......................9167
(2) Dextropropoxyphene (alpha-(+)-4-dimethylamino-1, 2-diphenyl-
3-methyl-2-propion-oxybutane).............................................. 9278
(3) 2-[(dimethylamino)methyl]-1-(3-methoxyphenyl)cyclohexanol,
its salts, optical and geometric isomers and salts of these isomers
(including tramadol)................................................................ 9752
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
HB 2765 29
(g) Butyl nitrite and its salts, isomers, esters, ethers or their salts.
(h) The board may except by rule and regulation any compound,
mixture or preparation containing any depressant substance listed in
subsection (b) from the application of all or any part of this act if the
compound, mixture or preparation contains one or more active medicinal
ingredients not having a depressant effect on the central nervous system,
and if the admixtures are included therein in combinations, quantity,
proportion or concentration that vitiate the potential for abuse of the
substances that have a depressant effect on the central nervous system.
Sec. 5. K.S.A. 65-4109 and K.S.A. 2025 Supp. 21-5701, 65-4105 and
65-4111 are hereby repealed.
Sec. 6. This act shall take effect and be in force from and after its
publication in the statute book.
1
2
3
4
5
6
7
8
9
10
11
12
13